SCHEMBL29370778

SCHEMBL29370778

NC(=O)n1ccc2ccccc21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.66
TSHR P16473 1/20 0.61
RAB9A P51151 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
PARP1 P09874 4/20 0.53
LMNA P02545 1/20 0.51
KMT2A Q03164 1/20 0.47
TFPI2 P48307 1/20 0.45
NPY4R P50391 1/20 0.45
GAA P10253 1/20 0.45
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNA7 P36544 1/20 0.43
CHRNA4 P43681 1/20 0.43
HTR3A P46098 1/20 0.43
HTR3D Q70Z44 1/20 0.43
HTR3C Q8WXA8 1/20 0.43
CDK4 P11802 3/20 0.42
CCND1 P24385 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3649822 1.00 NOTUM (0.66) NOTUMTSHRRAB9AL3MBTL1PARP1
Hydrochloric Acid SCHEMBL16237239 0.98 NOTUM (0.63) NOTUMTSHRRAB9AL3MBTL1PARP1
Hydrochloric Acid SCHEMBL28843911 0.96 NOTUM (0.61) NOTUMTSHRRAB9AL3MBTL1PARP1
Isopropyl Alcohol SCHEMBL11540475 0.91 NOTUM (0.61) NOTUMTSHRRAB9AL3MBTL1PARP1
SCHEMBL29195129 0.89 NOTUM (0.59) NOTUMTSHRRAB9AL3MBTL1PARP1
SCHEMBL931955 0.85 TSHR (0.69) NOTUMTSHRRAB9AL3MBTL1LMNA
SCHEMBL29453277 0.85 TSHR (0.69) NOTUMTSHRRAB9AL3MBTL1LMNA
SCHEMBL2079635 0.84 NOTUM (0.61) NOTUMTSHRRAB9AL3MBTL1PARP1
Bromide SCHEMBL19150274 0.83 TSHR (0.67) NOTUMTSHRRAB9AL3MBTL1LMNA
Hydrochloric Acid SCHEMBL20610213 0.83 TSHR (0.67) NOTUMTSHRRAB9AL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119185569-A Sustained release delivery system comprising a traceless linker 诺华股份有限公司 2024-12-27 CN claimed
WO-2022025150-A1 THERAPEUTIC AGENT FOR BREAST CANCER エーザイ・アール・アンド・ディー・マネジメント株式会社 2022-02-03 WO claimed
EP-4608817-A1 COMPOUNDS AND METHODS FOR TREATING CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-09-03 EP disclosed
WO-2025090460-A1 COMPOUNDS AND METHODS FOR TREATING CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-05-01 WO disclosed
EP-4543841-A2 CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES The University of North Carolina at Chapel Hill (US) 2025-04-30 EP disclosed
EP-4444290-A1 STAT3 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-10-16 EP disclosed
WO-2024091450-A1 COMPOUNDS AND METHODS FOR TREATING CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-05-02 WO disclosed
WO-2023250180-A2 CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2023-12-28 WO disclosed
WO-2023107706-A1 STAT3 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-06-15 WO disclosed
EP-4073037-A1 SMALL MOLECULE INHIBITORS OF VOLTAGE-GATED SODIUM CHANNEL 1.7 AND METHODS OF USING SAME Duke University (US) 2022-10-19 EP disclosed